# Rapport Therapeutics, Inc.: Form 8-K, filed Sep 10, 2025

- Company: [Rapport Therapeutics, Inc.](/companies/rapp.md) (CIK 2012593)
- Form: 8-K
- Filed: 2025-09-10
- Accepted by EDGAR: Sep 10, 2025, 17:22 ET
- Period: 2025-09-09
- Accession: 0001193125-25-200205
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/d907117d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/d907117d8k.htm

Filed Sep 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-200205. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.
